Israel Englander Vor Biopharma Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Millennium Management LLC holds 158,392 shares of VOR stock, worth $213,829. This represents 0.0% of its overall portfolio holdings.

Number of Shares

158,392

Holding current value

$213,829

% of portfolio

0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.8 - $2.85 $285,105 - $451,417	158,392 New	158,392 $375,000
Q2 2023 Aug 14, 2023	SELL	$3.09 - $5.33 $1.06 Million - $1.83 Million	-344,161 Reduced 84.59%	62,690 $193,000
Q1 2023 May 15, 2023	SELL	$4.68 - $6.96 $426,951 - $634,953	-91,229 Reduced 18.32%	406,851 $2.19 Million
Q4 2022 Feb 14, 2023	BUY	$3.98 - $7.43 $633,452 - $1.18 Million	159,159 Added 46.96%	498,080 $3.31 Million
Q3 2022 Nov 14, 2022	BUY	$4.36 - $5.52 $217,908 - $275,884	49,979 Added 17.3%	338,921 $1.35 Million

Others Institutions Holding VOR

# of Institutions

Shares Held

29M

Call Options Held

1.8K

Put Options Held

100

View Full List

About Vor Biopharma Inc.

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $51.4M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

More about VOR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account